<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl" type="text/xsl"?>
<document xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="urn:hl7-org:v3" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="301ed63e-05fc-077f-e063-6294a90a72ee"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>Erythromycin Ophthalmic Ointment USP, 0.5%</title>
   <effectiveTime value="20250312"/>
   <setId root="301ee5ad-3b6c-1152-e063-6294a90a54e7"/>
   <versionNumber value="1"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id root="1.3.6.1.4.1.519.1" extension="828374897"/>
            <name>Redpharm Drug</name>
            <assignedEntity>
               <assignedOrganization>
                  <assignedEntity>
                     <assignedOrganization>
                        <id root="1.3.6.1.4.1.519.1" extension="828374897"/>
                        <name>Redpharm Drug</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C73606" displayName="repack" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="67296-2128" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="301ef67e-53d9-198a-e063-6294a90ab137"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL product data elements section"/>
               <effectiveTime value="20250312"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="67296-2128" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Erythromycin</name>
                        <formCode code="C42966" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="OINTMENT"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Erythromycin</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <asEquivalentEntity classCode="EQUIV">
                           <code code="C64637" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <definingMaterialKind>
                              <code code="72485-670" codeSystem="2.16.840.1.113883.6.69"/>
                           </definingMaterialKind>
                        </asEquivalentEntity>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="T5L8T28FGP" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>MINERAL OIL</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="4T6H12BN9U" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>PETROLATUM</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="mg" value="5"/>
                              <denominator unit="g" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="63937KV33D" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>ERYTHROMYCIN</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="63937KV33D" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>ERYTHROMYCIN</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="3.5" unit="g"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C42794" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TUBE"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="67296-2128-3" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20231018"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="ANDA064030" root="2.16.840.1.113883.3.150"/>
                           <code code="C73584" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20231018"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38287" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="OPHTHALMIC"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="s1">
               <id root="301ee554-43eb-054b-e063-6294a90a36d0"/>
               <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
               <text>
                  <paragraph>
                     <content styleCode="bold">Sterile</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Rx only</content>
                  </paragraph>
               </text>
               <effectiveTime value="20231018"/>
            </section>
         </component>
         <component>
            <section ID="s3">
               <id root="301ee554-43ec-054b-e063-6294a90a36d0"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>DESCRIPTION:</title>
               <text>
                  <paragraph>Erythromycin Ophthalmic Ointment belongs to the macrolide group of antibiotics. It is basic and readily forms a salt when combined with an acid. The base, as crystals or powder, is slightly soluble in water, moderately soluble in ether, and readily soluble in alcohol or chloroform. Erythromycin ((3R*, 4S*, 5S*, 6R*, 7R*, 9R*, 11R*, 12R*, 13S*, 14R*)-4-[(2,6-dideoxy-3-C-methyl-3-
 
  <content styleCode="italics">O</content>-methyl-Î±-L-
 
  <content styleCode="italics">ribo</content>-hexopyranosyl)-oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethyl-amino)-Î²-D-
 
  <content styleCode="italics">xylo</content>-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione)) is an antibiotic produced from a strain of
 
  <content styleCode="italics">Streptomyces erythraeus.</content>
                  </paragraph>
                  <paragraph>It has the following structural formula:</paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="mm01"/>
                  </paragraph>
                  <paragraph>Each gram contains Erythromycin USP 5 mg in a sterile ophthalmic base of mineral oil and white petrolatum.</paragraph>
               </text>
               <effectiveTime value="20231018"/>
               <component>
                  <observationMedia ID="mm01">
                     <text>Structural Formula
</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="ery00-0008-01.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="s4">
               <id root="301ee554-43ed-054b-e063-6294a90a36d0"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>CLINICAL PHARMACOLOGY:</title>
               <effectiveTime value="20231018"/>
               <component>
                  <section ID="s5">
                     <id root="301ee554-43ee-054b-e063-6294a90a36d0"/>
                     <code code="49489-8" codeSystem="2.16.840.1.113883.6.1" displayName="MICROBIOLOGY SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="bold">
                              <content styleCode="italics">Microbiology:</content>
                           </content>Erythromycin inhibits protein synthesis without affecting nucleic acid synthesis. Erythromycin is usually active against the following organisms
 
  <content styleCode="italics">in vitro</content>and in clinical infections:

 </paragraph>
                        <paragraph>
                           <content styleCode="italics">Streptococcus pyogenes</content>(group A Î²-hemolytic)

 </paragraph>
                        <paragraph>Alpha-hemolytic streptococci (viridans group)</paragraph>
                        <paragraph>
                           <content styleCode="italics">Staphylococcus aureus</content>, including penicillinase-producing strains (methicillin-resistant staphylococci are uniformly resistant to erythromycin)

 </paragraph>
                        <paragraph>
                           <content styleCode="italics">Streptococcus pneumoniae</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="italics">Mycoplasma pneumoniae</content>(Eaton Agent, PPLO)

 </paragraph>
                        <paragraph>
                           <content styleCode="italics">Haemophilus influenzae</content>(not all strains of this organism are susceptible at the erythromycin concentrations ordinarily achieved)

 </paragraph>
                        <paragraph>
                           <content styleCode="italics">Treponema pallidum</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="italics">Corynebacterium diphtheriae</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="italics">Neisseria gonorrhoeae</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="italics">Chlamydia trachomatis</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20231018"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s6">
               <id root="301ee554-43ef-054b-e063-6294a90a36d0"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>INDICATIONS AND USAGE:</title>
               <text>
                  <paragraph>For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to erythromycin.</paragraph>
                  <paragraph>For prophylaxis of ophthalmia neonatorum due to
 
  <content styleCode="italics">N. gonorrhoeae</content>or
 
  <content styleCode="italics">C. trachomatis</content>.

 </paragraph>
                  <paragraph>The effectiveness of erythromycin in the prevention of ophthalmia caused by penicillinase-producing
 
  <content styleCode="italics">N.gonorrhoeae</content>is not established.

 </paragraph>
                  <paragraph>For infants born to mothers with clinically apparent gonorrhea, intravenous or intramuscular injections of aqueous crystalline penicillin G should be given; a single dose of 50,000 units for term infants or 20,000 units for infants of low birth weight. Topical prophylaxis alone is inadequate for these infants.</paragraph>
               </text>
               <effectiveTime value="20231018"/>
            </section>
         </component>
         <component>
            <section ID="s7">
               <id root="301ee554-43f0-054b-e063-6294a90a36d0"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>CONTRAINDICATIONS:</title>
               <text>
                  <paragraph>This drug is contraindicated in patients with a history of hypersensitivity to erythromycin.</paragraph>
               </text>
               <effectiveTime value="20231018"/>
            </section>
         </component>
         <component>
            <section ID="s8">
               <id root="301ee554-43f1-054b-e063-6294a90a36d0"/>
               <code code="42232-9" codeSystem="2.16.840.1.113883.6.1" displayName="PRECAUTIONS SECTION"/>
               <title>PRECAUTIONS:</title>
               <effectiveTime value="20231018"/>
               <component>
                  <section ID="s9">
                     <id root="301ee554-43f2-054b-e063-6294a90a36d0"/>
                     <code code="34072-9" codeSystem="2.16.840.1.113883.6.1" displayName="GENERAL PRECAUTIONS SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="bold">General:</content>The use of antimicrobial agents may be associated with the overgrowth of nonsusceptible organisms including fungi; in such a case, antibiotic administration should be stopped and appropriate measures taken.

 </paragraph>
                     </text>
                     <effectiveTime value="20231018"/>
                  </section>
               </component>
               <component>
                  <section ID="s10">
                     <id root="301ee554-43f3-054b-e063-6294a90a36d0"/>
                     <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="bold">Information for Patients:</content>Avoid contaminating the applicator tip with material from the eye, fingers, or other source.

 </paragraph>
                     </text>
                     <effectiveTime value="20231018"/>
                  </section>
               </component>
               <component>
                  <section ID="s11">
                     <id root="301ee554-43f4-054b-e063-6294a90a36d0"/>
                     <code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="bold">Carcinogenesis, Mutagenesis, Impairment of Fertility:</content>Two year oral studies conducted in rats with erythromycin did not provide evidence of tumorigenicity. Mutagenicity studies have not been conducted. No evidence of impaired fertility that appeared related to erythromycin was reported in animal studies.

 </paragraph>
                     </text>
                     <effectiveTime value="20231018"/>
                  </section>
               </component>
               <component>
                  <section ID="s12">
                     <id root="301ee554-43f5-054b-e063-6294a90a36d0"/>
                     <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="bold">Pregnancy:</content>Teratogenic Effects: Pregnancy Category B. Reproduction studies have been performed in rats, mice, and rabbits using erythromycin and its various salts and esters, at doses that were several multiples of the usual human dose. No evidence of harm to the fetus that appeared related to erythromycin was reported in these studies. There are, however, no adequate and well controlled studies in pregnant women. Because animal reproductive studies are not always predictive of human response, the erythromycins should be used during pregnancy only if clearly needed.

 </paragraph>
                     </text>
                     <effectiveTime value="20231018"/>
                  </section>
               </component>
               <component>
                  <section ID="s13">
                     <id root="301ee554-43f6-054b-e063-6294a90a36d0"/>
                     <code code="34080-2" codeSystem="2.16.840.1.113883.6.1" displayName="NURSING MOTHERS SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="bold">Nursing Mothers:</content>Caution should be exercised when erythromycin is administered to a nursing woman.

 </paragraph>
                     </text>
                     <effectiveTime value="20231018"/>
                  </section>
               </component>
               <component>
                  <section ID="s14">
                     <id root="301ee554-43f7-054b-e063-6294a90a36d0"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="bold">Pediatric Use -</content>See
 
  <content styleCode="bold">
                              <linkHtml href="#s6">INDICATIONS AND USAGE</linkHtml>
                           </content>and
 
  <content styleCode="bold">
                              <linkHtml href="#s17">DOSAGE AND ADMINISTRATION</linkHtml>.
 
  </content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20231018"/>
                  </section>
               </component>
               <component>
                  <section ID="s15">
                     <id root="301ee554-43f8-054b-e063-6294a90a36d0"/>
                     <code code="34082-8" codeSystem="2.16.840.1.113883.6.1" displayName="GERIATRIC USE SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="bold">Geriatric Use:</content>No overall differences in safety or effectiveness have been observed between elderly and younger patients.

 </paragraph>
                     </text>
                     <effectiveTime value="20231018"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s16">
               <id root="301ee554-43f9-054b-e063-6294a90a36d0"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>ADVERSE REACTIONS:</title>
               <text>
                  <paragraph>The most frequently reported adverse reactions are minor ocular irritations, redness, and hypersensitivity reactions.</paragraph>
               </text>
               <effectiveTime value="20231018"/>
            </section>
         </component>
         <component>
            <section ID="s17">
               <id root="301ee554-43fa-054b-e063-6294a90a36d0"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>DOSAGE AND ADMINISTRATION:</title>
               <text>
                  <paragraph>In the treatment of superficial ocular infections, a ribbon approximately 1 cm in length of Erythromycin Opthalmic Ointment should be applied directly to the infected structure up to 6 times daily, depending on the severity of the infection.</paragraph>
                  <paragraph>For prophylaxis of neonatal gonococcal or chlamydial conjunctivitis, a ribbon of ointment approximately 1 cm in length should be instilled into each lower conjunctival sac. The ointment should not be flushed from the eye following instillation. A new tube should be used for each infant.</paragraph>
               </text>
               <effectiveTime value="20231018"/>
            </section>
         </component>
         <component>
            <section ID="s18">
               <id root="301ee554-43fb-054b-e063-6294a90a36d0"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>HOW SUPPLIED:</title>
               <text>
                  <paragraph>Sterile Erythromycin Ophthalmic Ointment USP, 0.5% is available as follows:</paragraph>
                  <paragraph>3.5 g (1/8 oz) sterile tamper-resistant tube (NDC 72485-670-35)</paragraph>
                  <paragraph>Carton of fifty (50) Unit Dose 1 g tube (NDC 72485-670-31)</paragraph>
               </text>
               <effectiveTime value="20231018"/>
               <component>
                  <section ID="s19">
                     <id root="301ee554-43fc-054b-e063-6294a90a36d0"/>
                     <code code="44425-7" codeSystem="2.16.840.1.113883.6.1" displayName="STORAGE AND HANDLING SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="bold">STORAGE:</content>Store at 20Â° to 25Â°C (68Â° to 77Â°F) [see USP Controlled Room Temperature].

 </paragraph>
                        <paragraph>Avoid excessive heat.</paragraph>
                        <paragraph>Protect from freezing.</paragraph>
                        <paragraph/>
                        <paragraph>
                           <content styleCode="bold">Distributed by:</content>
                        </paragraph>
                        <paragraph>Armas Pahrmaceuticals, Inc.</paragraph>
                        <paragraph>Freehold, NJ 07728 (USA)</paragraph>
                        <paragraph/>
                        <paragraph>
                           <content styleCode="bold">Manufactured by:</content>
                        </paragraph>
                        <paragraph>Ophtapharm AG, Riethofstrasse 1, Hellingen,</paragraph>
                        <paragraph>8442, Switzerland (CHE) for Sentiss</paragraph>
                        <paragraph/>
                        <paragraph>Made in Switzerland</paragraph>
                        <paragraph/>
                        <paragraph>83008101 Rev. 07/23</paragraph>
                     </text>
                     <effectiveTime value="20231018"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s20">
               <id root="301ee554-43fd-054b-e063-6294a90a36d0"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>Principal Display Panel Text for Container Label</title>
               <text>
                  <paragraph>NDC 72485-670-35</paragraph>
                  <paragraph>ERYTHROMYCIN OPHTHALMIC</paragraph>
                  <paragraph>OINTMENT USP, 0.5%</paragraph>
                  <paragraph>Rx only Sterile Net Wt. 3.5 g (1/8 oz.)</paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="img_08065357-c755-0edc-e063-6294a90a232f"/>
                  </paragraph>
                  <paragraph/>
                  <paragraph>NDC 72485-670-31</paragraph>
                  <paragraph>ERYTHROMYCIN OPHTHALMIC</paragraph>
                  <paragraph>OINTMENT USP, 0.5%</paragraph>
                  <paragraph>Rx only Sterile Net Wt. 1 g</paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="img_0862a45e-d9d5-5a3c-e063-6294a90a832d"/>
                  </paragraph>
                  <paragraph/>
                  <paragraph/>
               </text>
               <effectiveTime value="20231018"/>
               <component>
                  <observationMedia ID="img_08065357-c755-0edc-e063-6294a90a232f">
                     <text>35 label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="35  label.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="img_0862a45e-d9d5-5a3c-e063-6294a90a832d">
                     <text>Container label 31</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="31 label.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="s21">
               <id root="301ee554-43fe-054b-e063-6294a90a36d0"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>Principal Display Panel Text for Carton Label</title>
               <text>
                  <paragraph>3.5 g NDC 72485-670-35</paragraph>
                  <paragraph>ERYTHROMYCIN OPHTHALMIC</paragraph>
                  <paragraph>OINTMENT USP, 0.5%</paragraph>
                  <paragraph>Rx only Sterile Net Wt 3.5 g (1/8 oz.)</paragraph>
                  <paragraph/>
                  <paragraph>
                     <renderMultiMedia referencedObject="img_08066632-3720-6360-e063-6294a90a2b5e"/>
                  </paragraph>
                  <paragraph/>
                  <paragraph>1 g NDC 72485-670-31</paragraph>
                  <paragraph>ERYTHROMYCIN OPHTHALMIC</paragraph>
                  <paragraph>OINTMENT USP, 0.5%</paragraph>
                  <paragraph>Rx only Sterile Net Wt 1 g</paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="img_0862a76e-38e4-566f-e063-6294a90a9561"/>
                  </paragraph>
               </text>
               <effectiveTime value="20231018"/>
               <component>
                  <observationMedia ID="img_08066632-3720-6360-e063-6294a90a2b5e">
                     <text>35 container</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="35 container.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="img_0862a76e-38e4-566f-e063-6294a90a9561">
                     <text>container label 31</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="31 container.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>